About Orpyx®

Orpyx has created a wearable sensor platform to enable life-changing health tools and empower patients & practitioners through data analytics. Our platform enables a proxy feedback system. Orpyx is an anagram of proxy. Clever, huh?

Who are we?

Founded in 2010, Orpyx Medical Technologies empowers people with diabetes to maintain mobility and foot health. Orpyx’s core patented product, SurroSense Rx®, helps prevent foot ulcers and limb loss through FDA-cleared, advanced foot sensor technology and analytics, delivered in an easy-to-use ultra thin insole. Orpyx technology is used by researchers to access clinical-grade plantar pressure measurement data for health and human performance applications. Orpyx is focused on collaborating with stakeholders around the world to achieve a healthcare future that is prevention-focused and sustainable in cost.

Why we’re here

Orpyx came into existence to help address a huge problem that medicine and surgery face on a daily basis — the problem of diabetes and complications of diabetes. Many of these problems stem from one of the main complications of diabetes, “peripheral neuropathy” (or, numb feet). Without feedback, people are unaware when damage is being done and complications develop.

Where we’re going

Orpyx looks to the next five years with the objective of becoming the world leader in innovating and developing wearable sensor-based technologies and sensory substitution systems that provide consumers with quality solutions to better cope with disease and improve overall quality of life.

Our Leadership Team

Dr. Breanne Everett, MD, MBA

Dr. Breanne Everett, MD, MBA

CEO

Travis Stevens, P Eng

Travis Stevens, P Eng

VP Engineering

John Jahrstorfer

John Jahrstorfer

VP Sales & Marketing

Board & Advisors

Dr. Breanne Everett, MD, MBA

Dr. Breanne Everett, MD, MBA

CEO

David McFaul

David McFaul

Director

David Taylor, P Eng, MBA

David Taylor, P Eng, MBA

Director

Dr. Robert Bray, MD, FRCSC

Dr. Robert Bray, MD, FRCSC

Director

Dr. Jeffrey Lehrman

Dr. Jeffrey Lehrman

Advisor

Contact Us

info@orpyx.com
1.855.996.7799

U.S. Patent No. 10,004,428 - June 2018
U.S. Patent No. 9,778,131 B2 - October 2017
U.S. Patent No. D740,950 S - October 2015
Australia Patent No. 2011320072 - May 2016
Japan Patent No. 6004444 - October 2016
New Zealand Patent No. 611197 - November 2015

Subscribe to our newsletter
* indicates required